China SXT Pharmaceuticals, Inc. (SXTC)
USD 0.34
(-1.79%)
USD 0.34
(-1.79%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.92 Million | 1.97 Million | 2.6 Million | 4.77 Million | 5.16 Million | 7.01 Million |
| Cost of Revenue | 1.37 Million | 1.54 Million | 1.35 Million | 1.93 Million | 2.45 Million | 2.4 Million |
| Gross Profit | 553.97 Thousand | 426.27 Thousand | 1.25 Million | 2.83 Million | 2.7 Million | 4.61 Million |
| Operating Expenses | 3.06 Million | 6.03 Million | 6.44 Million | 5.03 Million | 4.04 Million | 2.84 Million |
| Selling, General and Administrative Expenses | 3.06 Million | 6.03 Million | 6.44 Million | 5.03 Million | 4.04 Million | 2.84 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 149.51 Thousand | -181.58 Thousand | 871.65 Thousand | -73.77 Thousand | 27.14 Thousand |
| Cost and Expenses | 4.44 Million | 7.57 Million | 7.79 Million | 6.97 Million | 6.5 Million | 5.24 Million |
| Operating Income | -2.51 Million | -5.6 Million | -5.18 Million | -2.19 Million | 4.28 Million | 1.76 Million |
| Interest Expense | 544.27 Thousand | 476.77 Thousand | 218.27 Thousand | 1.61 Million | 3.34 Million | 5174.00 |
| Income Tax Expense | - | 476.77 Thousand | 328.14 Thousand | -192.68 Thousand | -101.72 Thousand | 252.23 Thousand |
| Earnings before Tax | -3.09 Million | -5.93 Million | -5.4 Million | -2.94 Million | -10.38 Million | 1.79 Million |
| Net Income | -3.09 Million | -5.93 Million | -5.73 Million | -2.74 Million | -10.28 Million | 1.53 Million |
| Earnings Per Share Basic | -3.57 | -22.23 | -137.92 | -95.48 | -832.08 | 149.67 |
| Earnings Per Share Diluted | -3.57 | -22.23 | -137.92 | -95.48 | -832.08 | 149.67 |
| Weighted Average Shares Outstanding | 867.42 Thousand | 266.97 Thousand | 41.59 Thousand | 28.78 Thousand | 12.36 Thousand | 10.28 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 867.42 Thousand | 266.97 Thousand | 41.59 Thousand | 28.78 Thousand | 12.36 Thousand | 10.28 Thousand |
| Gross Margin | 0.29 | 0.22 | 0.48 | 0.59 | 0.52 | 0.66 |
| EBIT Margin | -1.22 | -2.72 | -1.87 | -0.39 | 0.89 | 0.28 |
| Profit Margin | -1.61 | -3.01 | -2.20 | -0.58 | -1.99 | 0.22 |
| EBITDA | -2.35 Million | -5.2 Million | -5.05 Million | -1.85 Million | -1 Million | 1.95 Million |
| Earnings Before Tax Margin | -1.30 | -2.84 | -1.99 | -0.46 | 0.83 | 0.25 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 1.92 Million | 494.45 Thousand | 494.45 Thousand | 939.58 Thousand | 469.79 Thousand | 763.39 Thousand |
| Cost of Revenue | 1.37 Million | 361.64 Thousand | 361.64 Thousand | 753.99 Thousand | 325.62 Thousand | 426.8 Thousand |
| Gross Profit | 553.97 Thousand | 132.81 Thousand | 132.81 Thousand | 185.59 Thousand | 144.17 Thousand | 336.58 Thousand |
| Operating Expenses | 2.64 Million | -3.28 Million | -3.28 Million | 9.53 Million | 4.82 Million | 4.79 Million |
| Selling, General and Administrative Expenses | - | 3.49 Million | 3.49 Million | 9.53 Million | 4.81 Million | 4.79 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -39.03 Thousand | -6.77 Million | -6.77 Million | 1.00 | - | - |
| Cost and Expenses | 4.02 Million | -2.92 Million | -2.92 Million | 10.28 Million | 5.14 Million | 5.22 Million |
| Operating Income | -2.09 Million | 3.41 Million | 3.41 Million | -9.34 Million | -4.67 Million | -4.45 Million |
| Interest Expense | 544.27 Thousand | - | - | - | - | 92.49 Thousand |
| Income Tax Expense | 3.00 | 211.46 Thousand | 211.46 Thousand | - | - | 3.00 |
| Earnings before Tax | -3.09 Million | 3.29 Million | 3.29 Million | -9.69 Million | -4.84 Million | -4.44 Million |
| Net Income | -3.09 Million | 3.29 Million | 3.29 Million | -9.69 Million | -4.84 Million | -4.44 Million |
| Earnings Per Share Basic | - | 2.67 | 2.67 | -9.67 | -9.67 | -5.14 |
| Earnings Per Share Diluted | - | 2.67 | 2.67 | -9.67 | -9.67 | -5.14 |
| Weighted Average Shares Outstanding | 867.42 Thousand | 1.23 Million | 1.23 Million | 501.46 Thousand | 501.46 Thousand | 431.63 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 867.42 Thousand | 1.23 Million | 1.23 Million | 501.46 Thousand | 501.46 Thousand | 431.63 Thousand |
| Gross Margin | 0.29 | 0.27 | 0.27 | 0.20 | 0.31 | 0.44 |
| EBIT Margin | - | 7.44 | 7.44 | -9.84 | -9.84 | -5.65 |
| Profit Margin | -1.61 | 6.67 | 6.67 | -10.32 | -10.32 | -5.82 |
| EBITDA | - | 3.67 Million | 3.67 Million | -9.24 Million | -4.62 Million | -4.31 Million |
| Earnings Before Tax Margin | -1.08 | 6.91 | 6.91 | -9.95 | -9.95 | -5.84 |
KUMBF
002352
8030
NVG
WFC
6050